From: Liver transplantation in glycogen storage disease type I
 | GSDIa (n = 58) | GSDIb (n = 22) |
---|---|---|
Year of transplantation | 1982 – 2012 | 1991 – 2012 |
Indications | Â | Â |
Hepatic adenomas or liver abnormalities (mostly focal nodular hyperplasia) | Â | |
Poor metabolic control | ||
Growth retardation | ||
Recurrent infections | Â | |
Renal failure | 5 [36] | Â |
-Of which also kidney transplant | Â | |
Bleeding complications (anemia) | 1 [27] | Â |
Pancreatitis | 1 [24] | Â |
Anal and oral ulcera | Â | 1 [30] |
Immunosuppressive regime | Â | Â |
Cyclosporine | 1 [28] | |
Cyclosporine + azathioprine | - | |
Tacrolimus | ||
Not reported | 22 | 6 |
Outcome and complications GSDIa | Short-term (≤1 year) | Long-term (>1 year) |
Normalization liver function | 58 (all) | - |
Catch-up growth | - | |
Sexual maturation | - | 2 [25] |
Re-OLT | 1 [20] | |
Death | 1 (pancreatitis and sepsis) [25] | 3 (rejection related liver failure, suicide, metastatic hepatocellular carcinoma) [19], PC |
Renal failure | 6 [21] | 4 [20] |
-Of which already pre-transplant | 1 [39] | Â |
-Requiring dialysis | 1 [12] (temporary) | 2 [27], PC (permanent) |
-Gouty arthritis (due to renal failure?) | - | 1 [14] |
Metastatic hepatocellular carcinoma | 1PC | Â |
Transplantation associated | Â | Â |
-Hepatic artery thrombosis | - | |
-Portal vein thrombosis | - | |
-Hepatic vein obstruction | 2 [25] | - |
-Prolonged drainage | - | |
-Rejection | ||
-Never functioning liver after transplantation | Â | |
Therapy (immune suppression) associated | Â | Â |
-Hypertension | - | |
-Insulin-dependent diabetes (reversible) | - | |
-Infections (CMV, hepatitis) | 1 [14] | |
Outcome and complications GSDIb | Short-term (≤1 year) | Long-term (>1 year) |
Normalization liver function | 23 (all) | Â |
Catch-up growth | Â | 2 [32] |
Death | 1 (systemic candidiasis) [40] | Â |
Neutropenia | - | Â |
-Improved | - | |
-Persisted | Â | |
Thrombocytopenia | Â | 1 [28] |
Transplantation associated | Â | Â |
-Infection | 6 [34] | - |
-Anemia | 1 [33] | - |
-Rejection | - | 1 [13] |
Therapy (immune suppression) associated | Â | Â |
-Infection | 1 [30] | 1 [26] |
-Tacrolimus encephalopathy | 1 [35] | Â |